לונסורף 20 מג8.19 מג 以色列 - 希伯来文 - Ministry of Health

לונסורף 20 מג8.19 מג

medison pharma ltd - tipiracil as hydrochloride; trifluridine - טבליות מצופות פילם - tipiracil as hydrochloride 8.19 mg; trifluridine 20 mg - trifluridine, combinations

לונסורף 20 מג8.19מג 以色列 - 希伯来文 - Ministry of Health

לונסורף 20 מג8.19מג

medison pharma ltd - tipiracil as hydrochloride; trifluridine - טבליות מצופות פילם - tipiracil as hydrochloride 8.19 mg; trifluridine 20 mg - trifluridine, combinations

אנאסטרוזול אינובמד 1 מג 以色列 - 希伯来文 - Ministry of Health

אנאסטרוזול אינובמד 1 מג

inovamed ltd - anastrozole - טבליות מצופות פילם - anastrozole 1 mg - anastrozole - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

ביקאלוטמיד אינובמד 150 מג 以色列 - 希伯来文 - Ministry of Health

ביקאלוטמיד אינובמד 150 מג

inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable